The estimated incidence of<unk>  in children in the United States ranges from 35%- 45%. It is more common in the pediatric population. Race and gender have no predilection in<unk>  incidence.
Lymphadenopathy epidemiology and demographics
Vulvar cancer epidemiology and demographics
Prostate cancer epidemiology and demographics
Gynecomastia epidemiology and demographics
Vulvar cancer classification
Uterine cancer epidemiology and demographics
Carcinoid syndrome epidemiology and demographics
Endometrial cancer epidemiology and demographics